Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation

Steve N. Caritis; Hyagriv N. Simhan; Yuan Zhao; Dwight J. Rouse; Alan M. Peaceman; Anthony Sciscione; Catherine Y. Spong; Michael W. Varner; Fergal D. Malone; Jay D. Iams; Brian M. Mercer; John M. Thorp; Yoram Sorokin; Marshall Carpenter; Julie Lo; Susan M. Ramin; Margaret Harper

doi:10.1016/j.ajog.2012.08.001

Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation

Steve N. Caritis, Hyagriv N. Simhan, Yuan Zhao, Dwight J. Rouse, Alan M. Peaceman, Anthony Sciscione, Catherine Y. Spong, Michael W. Varner, Fergal D. Malone, Jay D. Iams, Brian M. Mercer, John M. Thorp, Yoram Sorokin, Marshall Carpenter, Julie Lo, Susan M. Ramin, Margaret Harper

Research output: Contribution to journal › Article › peer-review

34 Scopus citations

Abstract

Objective: We sought to evaluate in women with twin gestation the relationship between 17-hydroxyprogesterone caproate (17-OHPC) concentration and gestational age at delivery and select biomarkers of potential pathways of drug action. Study Design: Blood was obtained between 24-28 weeks (epoch 1) and 32-35 weeks (epoch 2) in 217 women with twin gestation receiving 17-OHPC or placebo. Gestational age at delivery and concentrations of 17-OHPC, 17-hydroxyprogesterone, progesterone, C-reactive protein (CRP), and corticotrophin-releasing hormone were assessed. Results: Women with higher concentrations of 17-OHPC delivered at earlier gestational ages than women with lower concentrations (P <.001). Women receiving 17-OHPC demonstrated significantly higher (P =.005) concentrations of CRP in epoch 1 than women receiving placebo but CRP values were similar in epoch 2 in both groups. A highly significant (P <.0001) positive relationship was observed between 17-OHPC concentration and progesterone and 17-hydroxyprogesterone concentrations at both epochs. Corticotropin-releasing hormone concentrations did not differ by treatment group. Conclusion: 17-OHPC may adversely impact gestational age at delivery in women with twin gestation.

Original language	English (US)
Pages (from-to)	396.e1-396.e8
Journal	American journal of obstetrics and gynecology
Volume	207
Issue number	5
DOIs	https://doi.org/10.1016/j.ajog.2012.08.001
State	Published - Nov 2012

Keywords

17-hydroxyprogesterone caproate
pharmacodynamics
twin gestation

ASJC Scopus subject areas

Obstetrics and Gynecology

Access to Document

10.1016/j.ajog.2012.08.001

Cite this

Caritis, S. N., Simhan, H. N., Zhao, Y., Rouse, D. J., Peaceman, A. M., Sciscione, A., Spong, C. Y., Varner, M. W., Malone, F. D., Iams, J. D., Mercer, B. M., Thorp, J. M., Sorokin, Y., Carpenter, M., Lo, J., Ramin, S. M., & Harper, M. (2012). Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation. American journal of obstetrics and gynecology, 207(5), 396.e1-396.e8. https://doi.org/10.1016/j.ajog.2012.08.001

Caritis, SN, Simhan, HN, Zhao, Y, Rouse, DJ, Peaceman, AM, Sciscione, A, Spong, CY, Varner, MW, Malone, FD, Iams, JD, Mercer, BM, Thorp, JM, Sorokin, Y, Carpenter, M, Lo, J, Ramin, SM & Harper, M 2012, 'Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation', American journal of obstetrics and gynecology, vol. 207, no. 5, pp. 396.e1-396.e8. https://doi.org/10.1016/j.ajog.2012.08.001

@article{cc5b2e3c18a24e05a2d8f2526d369803,

title = "Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation",

abstract = "Objective: We sought to evaluate in women with twin gestation the relationship between 17-hydroxyprogesterone caproate (17-OHPC) concentration and gestational age at delivery and select biomarkers of potential pathways of drug action. Study Design: Blood was obtained between 24-28 weeks (epoch 1) and 32-35 weeks (epoch 2) in 217 women with twin gestation receiving 17-OHPC or placebo. Gestational age at delivery and concentrations of 17-OHPC, 17-hydroxyprogesterone, progesterone, C-reactive protein (CRP), and corticotrophin-releasing hormone were assessed. Results: Women with higher concentrations of 17-OHPC delivered at earlier gestational ages than women with lower concentrations (P <.001). Women receiving 17-OHPC demonstrated significantly higher (P =.005) concentrations of CRP in epoch 1 than women receiving placebo but CRP values were similar in epoch 2 in both groups. A highly significant (P <.0001) positive relationship was observed between 17-OHPC concentration and progesterone and 17-hydroxyprogesterone concentrations at both epochs. Corticotropin-releasing hormone concentrations did not differ by treatment group. Conclusion: 17-OHPC may adversely impact gestational age at delivery in women with twin gestation.",

keywords = "17-hydroxyprogesterone caproate, pharmacodynamics, twin gestation",

author = "Caritis, {Steve N.} and Simhan, {Hyagriv N.} and Yuan Zhao and Rouse, {Dwight J.} and Peaceman, {Alan M.} and Anthony Sciscione and Spong, {Catherine Y.} and Varner, {Michael W.} and Malone, {Fergal D.} and Iams, {Jay D.} and Mercer, {Brian M.} and Thorp, {John M.} and Yoram Sorokin and Marshall Carpenter and Julie Lo and Ramin, {Susan M.} and Margaret Harper",

year = "2012",

month = nov,

doi = "10.1016/j.ajog.2012.08.001",

language = "English (US)",

volume = "207",

pages = "396.e1--396.e8",

journal = "American journal of obstetrics and gynecology",

issn = "0002-9378",

publisher = "Mosby Inc.",

number = "5",

}

TY - JOUR

T1 - Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation

AU - Caritis, Steve N.

AU - Simhan, Hyagriv N.

AU - Zhao, Yuan

AU - Rouse, Dwight J.

AU - Peaceman, Alan M.

AU - Sciscione, Anthony

AU - Spong, Catherine Y.

AU - Varner, Michael W.

AU - Malone, Fergal D.

AU - Iams, Jay D.

AU - Mercer, Brian M.

AU - Thorp, John M.

AU - Sorokin, Yoram

AU - Carpenter, Marshall

AU - Lo, Julie

AU - Ramin, Susan M.

AU - Harper, Margaret

PY - 2012/11

Y1 - 2012/11

N2 - Objective: We sought to evaluate in women with twin gestation the relationship between 17-hydroxyprogesterone caproate (17-OHPC) concentration and gestational age at delivery and select biomarkers of potential pathways of drug action. Study Design: Blood was obtained between 24-28 weeks (epoch 1) and 32-35 weeks (epoch 2) in 217 women with twin gestation receiving 17-OHPC or placebo. Gestational age at delivery and concentrations of 17-OHPC, 17-hydroxyprogesterone, progesterone, C-reactive protein (CRP), and corticotrophin-releasing hormone were assessed. Results: Women with higher concentrations of 17-OHPC delivered at earlier gestational ages than women with lower concentrations (P <.001). Women receiving 17-OHPC demonstrated significantly higher (P =.005) concentrations of CRP in epoch 1 than women receiving placebo but CRP values were similar in epoch 2 in both groups. A highly significant (P <.0001) positive relationship was observed between 17-OHPC concentration and progesterone and 17-hydroxyprogesterone concentrations at both epochs. Corticotropin-releasing hormone concentrations did not differ by treatment group. Conclusion: 17-OHPC may adversely impact gestational age at delivery in women with twin gestation.

AB - Objective: We sought to evaluate in women with twin gestation the relationship between 17-hydroxyprogesterone caproate (17-OHPC) concentration and gestational age at delivery and select biomarkers of potential pathways of drug action. Study Design: Blood was obtained between 24-28 weeks (epoch 1) and 32-35 weeks (epoch 2) in 217 women with twin gestation receiving 17-OHPC or placebo. Gestational age at delivery and concentrations of 17-OHPC, 17-hydroxyprogesterone, progesterone, C-reactive protein (CRP), and corticotrophin-releasing hormone were assessed. Results: Women with higher concentrations of 17-OHPC delivered at earlier gestational ages than women with lower concentrations (P <.001). Women receiving 17-OHPC demonstrated significantly higher (P =.005) concentrations of CRP in epoch 1 than women receiving placebo but CRP values were similar in epoch 2 in both groups. A highly significant (P <.0001) positive relationship was observed between 17-OHPC concentration and progesterone and 17-hydroxyprogesterone concentrations at both epochs. Corticotropin-releasing hormone concentrations did not differ by treatment group. Conclusion: 17-OHPC may adversely impact gestational age at delivery in women with twin gestation.

KW - 17-hydroxyprogesterone caproate

KW - pharmacodynamics

KW - twin gestation

UR - http://www.scopus.com/inward/record.url?scp=84868154962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868154962&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2012.08.001

DO - 10.1016/j.ajog.2012.08.001

M3 - Article

C2 - 22959763

AN - SCOPUS:84868154962

SN - 0002-9378

VL - 207

SP - 396.e1-396.e8

JO - American journal of obstetrics and gynecology

JF - American journal of obstetrics and gynecology

IS - 5

ER -

Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this